- Home
- BN vs GSK Comparison
BN vs GSK Comparison
Compare BN & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BN
- GSK
- Stock Information
- Founded
- BN 1997
- GSK 1715
- Country
- BN Canada
- GSK United Kingdom
- Employees
- BN N/A
- GSK N/A
- Industry
- BN Other Consumer Services
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- BN Consumer Discretionary
- GSK Health Care
- Exchange
- BN Nasdaq
- GSK Nasdaq
- Market Cap
- BN 83.6B
- GSK 68.2B
- IPO Year
- BN N/A
- GSK N/A
- Fundamental
- Price
- BN $58.17
- GSK $33.43
- Analyst Decision
- BN Buy
- GSK Hold
- Analyst Count
- BN 6
- GSK 5
- Target Price
- BN $54.83
- GSK $45.50
- AVG Volume (30 Days)
- BN 2.3M
- GSK 3.6M
- Earning Date
- BN 02-13-2025
- GSK 02-05-2025
- Dividend Yield
- BN 0.55%
- GSK 4.66%
- EPS Growth
- BN N/A
- GSK N/A
- EPS
- BN 0.47
- GSK 0.81
- Revenue
- BN $93,222,000,000.00
- GSK $41,966,224,352.00
- Revenue This Year
- BN N/A
- GSK $5.80
- Revenue Next Year
- BN $16.37
- GSK $3.69
- P/E Ratio
- BN $119.37
- GSK $20.19
- Revenue Growth
- BN N/A
- GSK 5.59
- 52 Week Low
- BN $38.18
- GSK $31.72
- 52 Week High
- BN $62.44
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- BN 54.45
- GSK 46.70
- Support Level
- BN $56.63
- GSK $31.72
- Resistance Level
- BN $58.77
- GSK $34.46
- Average True Range (ATR)
- BN 1.35
- GSK 0.47
- MACD
- BN 0.07
- GSK 0.01
- Stochastic Oscillator
- BN 87.83
- GSK 62.41
About BN Brookfield Corporation Limited Voting Shares
Brookfield Corp is an investment firm focused on building long-term wealth for institutions and individuals. It has three businesses Asset Management, Insurance Solutions, and Operating Businesses. it invests in real assets that form the backbone of the economy to deliver risk-adjusted returns to stakeholders. It generates the majority of its revenue from Asset Management. It has a geographic presence in the UK, the United States, Australia, Canada, Brazil, India, and other countries.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.